Paul Tudor Jones Myriad Genetics Inc Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Myriad Genetics Inc stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 15,998 shares of MYGN stock, worth $244,769. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,998

Holding current value

$244,769

% of portfolio

0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.97 - $28.6 $383,472 - $457,542	15,998 New	15,998 $437,000
Q4 2023 Feb 14, 2024	BUY	$13.91 - $21.32 $62,595 - $95,940	4,500 Added 43.45%	14,856 $284,000
Q3 2023 Nov 15, 2023	SELL	$15.99 - $23.22 $548,824 - $796,980	-34,323 Reduced 76.82%	10,356 $166,000
Q2 2023 Aug 14, 2023	BUY	$17.56 - $23.76 $23,547 - $31,862	1,341 Added 3.09%	44,679 $1.04 Million
Q1 2023 May 15, 2023	BUY	$15.26 - $23.75 $82,602 - $128,558	5,413 Added 14.27%	43,338 $1.01 Million
Q4 2022 Feb 14, 2023	SELL	$14.51 - $20.99 $33,605 - $48,612	-2,316 Reduced 5.76%	37,925 $550,000
Q3 2022 Nov 14, 2022	BUY	$18.21 - $27.88 $56,833 - $87,013	3,121 Added 8.41%	40,241 $768,000
Q2 2022 Aug 15, 2022	SELL	$16.45 - $25.88 $76,508 - $120,367	-4,651 Reduced 11.13%	37,120 $674,000
Q1 2022 May 16, 2022	BUY	$22.67 - $28.01 $632,470 - $781,450	27,899 Added 201.12%	41,771 $1.05 Million
Q4 2021 Feb 14, 2022	BUY	$24.13 - $32.63 $334,731 - $452,643	13,872 New	13,872 $383,000
Q2 2021 Aug 16, 2021	SELL	$25.39 - $32.61 $1.42 Million - $1.82 Million	-55,845 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$19.92 - $31.6 $694,331 - $1.1 Million	-34,856 Reduced 38.43%	55,845 $1.7 Million
Q4 2020 Feb 16, 2021	BUY	$12.16 - $19.77 $440,605 - $716,346	36,234 Added 66.52%	90,701 $1.79 Million
Q3 2020 Nov 16, 2020	SELL	$11.25 - $14.75 $245,216 - $321,505	-21,797 Reduced 28.58%	54,467 $710,000
Q2 2020 Aug 14, 2020	BUY	$10.69 - $16.49 $815,262 - $1.26 Million	76,264 New	76,264 $865,000
Q3 2019 Nov 14, 2019	SELL	$22.08 - $47.08 $2.22 Million - $4.74 Million	-100,707 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$22.67 - $35.0 $221,123 - $341,390	-9,754 Reduced 8.83%	100,707 $2.8 Million
Q1 2019 May 15, 2019	BUY	$26.93 - $34.7 $925,099 - $1.19 Million	34,352 Added 45.14%	110,461 $3.67 Million
Q4 2018 Feb 14, 2019	BUY	$27.23 - $45.56 $569,760 - $953,297	20,924 Added 37.92%	76,109 $2.21 Million
Q3 2018 Nov 14, 2018	BUY	$37.57 - $50.34 $523,688 - $701,689	13,939 Added 33.79%	55,185 $2.54 Million
Q2 2018 Aug 14, 2018	BUY	$27.75 - $40.17 $678,182 - $981,714	24,439 Added 145.41%	41,246 $1.54 Million
Q1 2018 May 15, 2018	BUY	$28.83 - $41.01 $484,545 - $689,255	16,807 New	16,807 $497,000

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.9M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.23B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account